OncoSec Announces $3.0 Million Private Placement Transaction

OncoSec closes the sale to institutional investors of an aggregate of 4,000,000 shares of its common stock at $0.75 per share in a private placement.  The gross proceeds of the offering are $3 million, and net proceeds come to approximately $2.79 million. OncoSec intends to use proceeds from the offering for further development of its electroporation therapies to treat cancers, clinical studies, and general corporate purposes.